SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending as the stock rallies, fueled by a new multi-launch contract and potential upside from government contracts. The community is buzzing about continued accumulation by institutional investors and the possibility of a gamma squeeze, while also debating valuation concerns amid the recent surge.  Enthusiasm remains high for the company's long-term prospects, particularly related to the Neutron launch and potential for space-based laser communication capabilities.

AlphaTON Capital Corp. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.

AlphaTON Capital Corp.

AlphaTON Capital Corp. is trending as community members discuss its potential for significant price movement, drawing comparisons to other low-float stocks that have recently experienced rapid gains. The company's focus on TON tokens and a strategic partnership are being highlighted, with some anticipating news related to crypto. Additionally, some traders are noting the stock's high short interest and low float.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending following news of a $75 million investment from an institutional investor, sparking speculation about the investor's identity with community members eyeing names like NVDA and LUMN.  The excitement centers around POET's Optical Interposer technology, which aims to improve AI data center efficiency. Community members are focused on potential new partnerships and the long-term growth prospects for the company.

BTQ Technologies Corp. engages in the business of post-quantum encryption. It focuses on applications to the blockchain industry. Its products include PQScale, Keelug, Kenting, Preon, QPoW, and QByte. The company was founded by Nicolas Roussy Newton on March 26, 2021 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies Corp is trending as investors are excited about the company's advancements in post-quantum cryptography, especially after the announcement of key semiconductor experts joining the team. Community discussions highlight BTQ's potential for growth in the quantum security space and its relatively low market cap compared to competitors, with some drawing comparisons to early-stage opportunities in the crypto market.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

GLTO is trending as traders actively discuss its recent volatile surge, drawing comparisons to other high-flying stocks like $SPRB. Community chatter revolves around potential short squeezes, low float dynamics, and whether it can sustain its gains. The stock's significant price movement and high trading volume are also key points of discussion.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending following an announcement of a $500M public offering of common stock, leading to a temporary dip in share price that the community is actively debating.  While some investors express concerns over dilution, others view this offering as a strategic move to fund expansion and accelerate the company's progress toward commercialization.  The community remains focused on the long-term potential of eVTOL technology and Joby's competitive position in the sector.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending due to discussions around a potential lock-up expiry impacting share prices, with some traders anticipating a buying opportunity while others express concerns about dilution. Community members are debating the stock's valuation, comparing it to competitors like Robinhood, and strategizing around options and potential price movements. Some are still optimistic, viewing the current dip as a chance to load up on shares, while others voice frustration with the stock's performance.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

$TMC is trending amid renewed interest in deep-sea mining, driven by discussions around government contracts and funding, particularly following a similar deal with $TMQ. Community members are actively discussing potential short squeezes and the long-term prospects of the company in the critical minerals market. Bullish sentiment is fueled by anticipation of regulatory approvals and the potential for significant growth in the electric vehicle and defense sectors.

Fitell Corp. engages in the business of selling gym and fitness equipment. It also offers turnkey solution for personal training studios and commercial gym chains. Its brands include Muscle Motion, Rapid Motion, and FleetX. The company was founded in 2007 and is headquartered in Sydney, Australia.

Fitell Corp - Ordinary Shares - Class A

Fitell Corp

FTEL is trending due to its low float and recent news regarding Solana treasury expansion and Nasdaq extension approval, leading to speculation of a potential breakout; the community is actively discussing squeeze potential and price target of 19.25, with some noting price discrepancies across different platforms; others are considering the stock as a potential play in the fitness equipment sector.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending due to anticipation surrounding upcoming data releases and presentations, especially regarding their gene therapy programs. Community members are actively discussing the potential impact of this data on regulatory approvals and the company's market position, with some speculating about a short squeeze. Positive sentiment is building around the long-term potential of Sarepta's pipeline, including their work with RNA therapies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Clover Health Investments (CLOV) Outperforming Other Medical Stocks This Year?

Here is how Clover Health Investments, Corp. (CLOV) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.

Fast-paced Momentum Stock Clover Health Investments (CLOV) Is Still Trading at a Bargain

Clover Health Investments (CLOV) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Here's Why You Should Add CLOV Stock to Your Portfolio Now

Clover's strong membership growth, rising revenues, and first-half EBITDA profitability highlight its tech-driven Medicare Advantage edge.

Bears are Losing Control Over Clover Health Investments (CLOV), Here's Why It's a 'Buy' Now

Clover Health Investments (CLOV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View

Clover Health's Q2 revenues rise 34%, but raised Insurance BER guidance and margin pressures cause shares to tumble post-earnings.

Clover Health Investments, Corp. (CLOV) Q2 Earnings Meet Estimates

Clover Health Investments (CLOV) delivered earnings and revenue surprises of 0.00% and -1.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Clover Health Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?

CLOV's second-quarter results are likely to reflect strong Medicare Advantage membership growth and expansion and deeper integration of Clover Assistant.

Centene Pulls 2025 Guidance as Marketplace Growth Falters

CNC pulls its 2025 forecast after a $1.8B risk adjustment shortfall. Also, weak Marketplace growth shakes investor confidence.

Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment

CI to cover RhinAer for chronic rhinitis starting Sept. 15, expanding access to a minimally invasive, office-based treatment.

Here's Why MOH Shares Are Attracting Prudent Investors Now

Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. The company was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Wilmington, DE.

Clover Health Investments Corp - Ordinary Shares - Class A

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

CLOV Clover Health Investments Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CLOV News